Druggable Targets and Materials to Enable Soft Connective Tissue Repair

This campaign has been commissioned by an international Japanese pharmaceutical company who combat diseases with a combination of ground‑breaking technology and biology, with an extensive track record of academic collaboration. They are seeking a solution that enables connective soft tissue repair, via either structural materials or druggable targets.

Specific Points of Interest:

• Therapeutic target activating, recruiting or proliferating endogenous MSCs/ progenitor cells
• Injectable glue or filler to enable soft connective tissue repair, especially meniscus...